| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Neurable
Neurable is a neurotechnology company focused on developing AI tools for brain s…
|
Boston | — | $57.3M | Series A | 2025-12-19 |
| 2 |
Neuralink
Neuralink is a neurotechnology company that focuses on developing brain-computer…
|
Fremont | 251 - 500 | $1.3B | Series Unknown | 2025-07-07 |
| 3 |
BrainCo
BrainCo develops brain-computer interface technologies for wellness and educatio…
|
Somerville | 101 - 250 | $1.2B | Series Unknown | 2026-01-06 |
| 4 |
SciNeuro
SciNeuro is a clinical-stage biotechnology company focused on developing groundb…
|
Rockville | 11 - 50 | $158.0M | Series Unknown | 2025-12-04 |
| 5 |
Wearable Devices
Wearable Devices is a growth company that produces AI touch wristbrands that use…
|
Yoqne`am `illit | 1 - 10 | $27.9M | Grant | 2025-12-11 |
| 6 |
Tivic Health
Tivic Health is a commercial health tech company that develops bioelectronic med…
|
Menlo Park | 11 - 50 | $81.0M | Post Ipo Equity | 2025-12-11 |
| 7 |
NRG Therapeutics
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches …
|
Cambridge | 11 - 50 | $97.3M | Series B | 2025-09-08 |
| 8 |
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized c…
|
San Diego | 101 - 250 | $387.0M | Series C | 2025-11-20 |
| 9 |
Kenai Therapeutics
Kenai Therapeutics focuses on developing therapies for neurodegenerative movemen…
|
San Diego | 11 - 50 | $97.0M | Grant | 2026-01-05 |
| 10 |
Subsense
Subsense develops non-surgical brain-computer interface (BCI) technologies that …
|
Covina | 1 - 10 | $27.0M | Seed | 2025-12-11 |
| 11 |
Nyxoah
Nyxoah is a medical device company focused on the development and commercializat…
|
Mont-saint-guibert | 101 - 250 | $287.7M | Post Ipo Equity | 2025-11-13 |
| 12 |
Science
Science is a clinical-stage medical technology company focusing on neuroscience …
|
Alameda | 101 - 250 | $407.3M | Series C | 2026-03-05 |
| 13 |
Novoron Bioscience
Biotechnology company developing pharmaceutical therapies for nerve regeneration…
|
San Diego | 11 - 50 | $18.7M | Grant | 2026-01-06 |
| 14 |
GT Medical Technologies
GT Medical Technologies is a medical device company that offers innovative medic…
|
Tempe | 51 - 100 | $162.5M | Series D | 2025-01-16 |
| 15 |
Kriya Therapeutics
Kriya Therapeutics is a biopharmaceutical company that develops gene therapies f…
|
Palo Alto | 101 - 250 | $921.3M | Series D | 2025-08-15 |
| 16 |
INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build t…
|
Barcelona | 51 - 100 | $119.8M | Grant | 2025-05-06 |
| 17 |
Flow Neuroscience
Flow Neuroscience is a healthcare company that develops direct current stimulati…
|
Malm├╢ | 11 - 50 | $12.6M | Series Unknown | 2026-02-09 |
| 18 |
QV Bioelectronics
Longer, Better Quality Lives for Brain Tumour Patients
|
Manchester | 11 - 50 | $12.8M | Grant | 2026-01-21 |
| 19 |
Indivi
Indivi develops functional biomarkers that measure key disability concepts of im…
|
Basel | 51 - 100 | $23.0M | Series Unknown | 2025-11-12 |
| 20 |
.lumen
.lumen is the deeptech startup that develops Pedestrian Autonomous Driving AI, f…
|
Cluj-napoca | 51 - 100 | $33.0M | Grant | 2025-10-20 |
| 21 |
Omniscient Neurotechnology
Omniscient develops AI and data-driven solutions to improve treatment for brain …
|
Sydney | 51 - 100 | $57.2M | Series D | 2026-01-16 |
| 22 |
Ashvattha Therapeutics
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develo…
|
Redwood City | 11 - 50 | $148.0M | Series B | 2025-01-13 |
| 23 |
Circular Genomics
Circular Genomics is a biotechnology and genomics company that develops RNA-base…
|
Albuquerque | 11 - 50 | $28.1M | Series A | 2025-12-01 |
| 24 |
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates pre…
|
Los Altos | 51 - 100 | $421.0M | Post Ipo Equity | 2026-03-16 |
| 25 |
Earable Neuroscience
FRENZ Brainband & Sleep Science Mobile app for improved sleep and unleashed huma…
|
Boulder | 51 - 100 | $8.7M | Convertible Note | 2023-06-21 |
| 26 |
Cala Health
Cala Health is a bioelectronic medicine company that develops wearable neuromodu…
|
San Mateo | 51 - 100 | $248.3M | Series C | 2025-10-20 |
| 27 |
Saluda Medical
Saluda Medical is a commercial-stage medical device company that develops treatm…
|
Bloomington | 251 - 500 | $529.5M | Undisclosed | 2025-11-12 |
| 28 |
Sinopia Biosciences
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics d…
|
San Diego | 1 - 10 | $17.0M | Grant | 2026-03-24 |
| 29 |
NeuroPace
NeuroPace develops and markets implantable devices for the treatment of neurolog…
|
Mountain View | 101 - 250 | $457.1M | Post Ipo Debt | 2025-06-04 |
| 30 |
Psilera
Psilera is a biotechnology company that develops treatments for neurological and…
|
Tampa | 1 - 10 | $7.6M | Grant | 2025-10-02 |
| 31 |
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and ot…
|
Cambridge | 101 - 250 | $623.5M | Post Ipo Equity | 2025-09-10 |
| 32 |
BrainScope
Brainscope is a medical neurotechnology company that improves brain health.
|
Bethesda | 11 - 50 | $87.1M | Series B | 2023-09-19 |
| 33 |
Cumulus Neuroscience
Cumulus Neuroscience has created a next-generation integrated physiological and …
|
Belfast | 11 - 50 | $15.9M | Series Unknown | 2025-07-08 |
| 34 |
Nido Biosciences
Nido Biosciences is a clinical-stage company that develops precision medicines f…
|
Watertown | 11 - 50 | $109.0M | Series B | 2023-05-15 |
| 35 |
CoMind
CoMind is a noninvasive neural technology company building next-generation neura…
|
London | 51 - 100 | $87.0M | Series A | 2025-10-20 |
| 36 |
Altoida
Altoida is creating a new gold standard in brain health with Precision Neurology…
|
Washington | 11 - 50 | $24.7M | Series A | 2022-03-30 |
| 37 |
Axonis Therapeutics
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the…
|
Boston | 11 - 50 | $129.6M | Series A | 2024-10-30 |
| 38 |
Verge Genomics
Verge Genomics uses machine learning and human genomics to accelerate drug disco…
|
San Francisco | 11 - 50 | $134.1M | Series Unknown | 2023-07-01 |
| 39 |
Cleveland Diagnostics
Cleveland Diagnostics is a diagnostics company developing efficacious, affordabl…
|
Cleveland | 51 - 100 | $125.4M | Undisclosed | 2025-10-20 |
| 40 |
Possibility Neurotechnologies
Creating simple and accessible brain-controlled technologies.
|
Calgary | 1 - 10 | $374K | Grant | 2025-06-01 |
| 41 |
Echo Neurotechnologies
Echo Neurotechnologies specializes in brain-machine interfaces that provide pati…
|
San Francisco | — | $50.0M | Series Unknown | 2025-01-31 |
| 42 |
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics f…
|
Cambridge | 51 - 100 | $180.0M | Post Ipo Equity | 2024-06-27 |
| 43 |
Flare Therapeutics
Flare Therapeutics is a biotech startup that creates precision therapies for can…
|
Cambridge | 51 - 100 | $205.0M | Series B | 2023-03-22 |
| 44 |
Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and cli…
|
Boston | 11 - 50 | $90.0M | Series A | 2023-11-08 |
| 45 |
Nudge
Nudge develops brain interface technology that helps to treat neurological probl…
|
San Francisco | 11 - 50 | $100.0M | Series A | 2025-07-22 |
| 46 |
NeuraLight
NeuraLight is a developer of neurology software designed to help patients affect…
|
Tel Aviv | 11 - 50 | $30.5M | Seed | 2022-05-24 |
| 47 |
Cognixion
Cognixion is a neural interface startup creates AI-powered products for individu…
|
Santa Barbara | 11 - 50 | $20.8M | Debt Financing | 2026-02-02 |
| 48 |
Elemind Technologies
Elemind Technologies is a neurotechnology company that shapes brainwaves and cha…
|
Cambridge | 11 - 50 | $12.0M | Seed | 2024-02-06 |
| 49 |
Cortica
Cortica provides neurological therapies for children with autism and other devel…
|
San Diego | 1K - 5K | $255.0M | Series Unknown | 2024-11-20 |
| 50 |
SEVARO
SEVARO is a healthcare technology company that provides teleneurology services f…
|
New York | 51 - 100 | $40.1M | Series B | 2025-09-18 |